Back to Search Start Over

A polygenic and phenotypic risk prediction for polycystic ovary syndrome evaluated by phenomewide association studies

Authors :
Joo, Y.Y. (Yoonjung Yoonie)
Actkins, K. (Ky'Era)
Pacheco, J.A. (Jennifer A.)
Basile, A.O. (Anna O.)
Carroll, R. (Robert)
Crosslin, D.R. (David)
Day, F.R. (Felix)
Denny, J.C. (Joshua C.)
Edwards, D.R.V. (Digna R. Velez)
Hakonarson, H. (Hakon)
Harley, J.B. (John B.)
Hebbring, S.J. (Scott J.)
Ho, K. (Kevin)
Jarvik, G.P. (Gail)
Jones, M.R. (Michelle)
Karaderi, T. (Tugce)
Mentch, F.D. (Frank D.)
Meun, C. (Cindy)
Namjou, B. (Bahram)
Pendergrass, S.A. (Sarah)
Ritchie, M.D. (Marylyn D.)
Stanaway, I.B. (Ian B.)
Urbanek, M. (Margrit)
Walunas, T.L. (Theresa L.)
Smith, M. (Maureen)
Chisholm, R.L. (Rex L.)
Kho, M.M.L. (Marcia)
Davis, L. (Lea)
Geoffrey Hayes, M. (M.)
Joo, Y.Y. (Yoonjung Yoonie)
Actkins, K. (Ky'Era)
Pacheco, J.A. (Jennifer A.)
Basile, A.O. (Anna O.)
Carroll, R. (Robert)
Crosslin, D.R. (David)
Day, F.R. (Felix)
Denny, J.C. (Joshua C.)
Edwards, D.R.V. (Digna R. Velez)
Hakonarson, H. (Hakon)
Harley, J.B. (John B.)
Hebbring, S.J. (Scott J.)
Ho, K. (Kevin)
Jarvik, G.P. (Gail)
Jones, M.R. (Michelle)
Karaderi, T. (Tugce)
Mentch, F.D. (Frank D.)
Meun, C. (Cindy)
Namjou, B. (Bahram)
Pendergrass, S.A. (Sarah)
Ritchie, M.D. (Marylyn D.)
Stanaway, I.B. (Ian B.)
Urbanek, M. (Margrit)
Walunas, T.L. (Theresa L.)
Smith, M. (Maureen)
Chisholm, R.L. (Rex L.)
Kho, M.M.L. (Marcia)
Davis, L. (Lea)
Geoffrey Hayes, M. (M.)
Publication Year :
2020

Abstract

Context: As many as 75% of patients with polycystic ovary syndrome (PCOS) are estimated tobe unidentified in clinical practice. Objective: Utilizing polygenic risk prediction, we aim to identify the phenome-widecomorbidity patterns characteristic of PCOS to improve accurate diagnosis and preventivetreatment.Design, Patients, and Methods: Leveraging the electronic health records (EHRs) of 124 852individuals, we developed a PCOS risk prediction algorithm by combining polygenic risk scores(PRS) with PCOS component phenotypes into a polygenic and phenotypic risk score (PPRS). Weevaluated its predictive capability across different ancestries and perform a PRS-based phenomewide association study (PheWAS) to assess the phenomic expression of the heightened risk ofPCOS.Results: The integrated polygenic prediction improved the average performance (pseudo-R2)for PCOS detection by 0.228 (61.5-fold), 0.224 (58.8-fold), 0.211 (57.0-fold) over the null modelacross European, African, and multi-ancestry participants respectively. The subsequent PRSpowered PheWAS identified a high level of shared biology between PCOS and a range ofmetabolic and endocrine outcomes, especially with obesity and diabetes: "morbid obesity","type 2 diabetes", "hypercholesterolemia", "disorders of lipid metabolism", "hypertension",and "sleep apnea" reaching phenome-wide significance.Conclusions: Our study has expanded the methodological utility of PRS in patient stratificationand risk prediction, especially in a multifactorial condition like PCOS, across different geneticorigins. By utilizing the individual genome-phenome data available from the EHR, our approachalso demonstrates that polygenic prediction by PRS can provide valuable opportunities todiscover the pleiotropic phenomic network associated with PCOS pathogenesis.Abbreviations: AA, African ancestry; ANOVA, analysis of variance; BMI, body mass index; EA,European ancestry; EHR, electronic health records; eMERGE, electronic Medical Records andGenomi

Details

Database :
OAIster
Notes :
application/pdf, Journal of Clinical Endocrinology and Metabolism vol. 105 no. 6, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1198971050
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1210.clinem.dgz326